Anodyne

Zolpidem
Zolpidem
Salts
[]
Zolpidem hydrobromide
Zolpidem hydrobromide
Zolpidem hydrochloride
Zolpidem hydrochloride
Zolpidem tartrate
Zolpidem tartrate
Molecular structure via molpic
Enable javascript to view conformer structure via 3Dmol.js
Molecular formulaC19H21N3O[1]
Molecular mass307.4 g/mol[1]
Predicted LogP2.5[1]
Melting point193-197[1]
Chiralityachiral[2]
Identifiers
[]
IUPAC nameN,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide[1]
SMILESCC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C[1]
InChIInChI=1S/C19H21N3O/c1-13-5-8-15(9-6-13)19-16(11-18(23)21(3)4)22-12-14(2)7-10-17(22)20-19/h5-10,12H,11H2,1-4H3[1]
InChIKeyZAFYATHCZYHLPB-UHFFFAOYSA-N[1]
Dosing
Elimination half-life2 – 3 hours[4]
Duration of action3 hours[5] [6]

Zolpidem

Zolpidem (also known as Zolpidemum, Sanval, Zolpidem civ, N,N-Dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide, N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide, SL800750, SL 800750, SL 80-0750, N,N,6-Trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide or N,n,6-trimethyl-2-p-tolyl-imidazo(1,2-a)pyridine-3-acetamide) is a substance of the imidazopyridine class.

Chemistry

Zolpidem is typically found in the form of its hydrobromide, hydrochloride and tartrate salts.

Stereochemistry

Zolpidem is a achiral mixture

Subjective effects

Experience reports

There are currently 25+ experience reports involving zolpidem on OpenErowid: []

See also

References

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 5732, Zolpidem. Accessed June 27, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/5732

  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Zolpidem. UNII: 7K383OQI23. Global Substance Registration System. Accessed June 27, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/7K383OQI23

  3. Scheduling of zolpidem (Stilnox). February 21, 2008. Accessed June 27, 2025. https://www.tga.gov.au/scheduling-zolpidem-stilnox

  4. Salvà P, Costa J. Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. Clinical Pharmacokinetics. September 1, 1995; 29(3):142–153.

  5. Sabe M, Kashef H, Gironi C, Sentissi O. Zolpidem stimulant effect: Induced mania case report and systematic review of cases. Progress in Neuro-Psychopharmacology & Biological Psychiatry. August 1, 2019; 94:109643.

  6. AMBIEN- zolpidem tartrate tablet, film coated. August 19, 2024. Accessed June 27, 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c36cadf4-65a4-4466-b409-c82020b42452